Psy93 - Cost Effectiveness of Letermovir as Prophylaxis of Clinically Significant Cytomegalovirus Reactivation and Disease in Adult CMV-Seropositive Allogeneic Haematopoietic Stem Cell Transplant: An English Payer Perspective

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2668

Related search